• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有证据时循证医学效果最佳:当无法进行随机对照试验时,姑息医学面临的挑战。

Evidence-based medicine works best when there is evidence: challenges in palliative medicine when randomized controlled trials are not possible.

作者信息

Kongsgaard Ulf E, Werner Mads U

机构信息

Department of Anaesthesia and Intensive Care, The Norwegian Radium Hospital, Rikshospitalet, Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

J Pain Palliat Care Pharmacother. 2009;23(1):48-50. doi: 10.1080/15360280902728237.

DOI:10.1080/15360280902728237
PMID:19296355
Abstract

Randomized controlled trials provide the best evidence for the safety and effectiveness of interventions. However, the reliance on this study design as the only criterion for credible evidence is not possible in all areas of palliative medicine. Although we must exercise caution in making definitive claims from uncontrolled trial data, limitations in performing controlled trials should neither preclude the use of findings from well-designed nonrandomized controlled trials nor, more importantly, deprive patients of potentially effective treatments.

摘要

随机对照试验为干预措施的安全性和有效性提供了最佳证据。然而,在姑息医学的所有领域,仅将这种研究设计作为可靠证据的唯一标准是不可能的。尽管我们在根据非对照试验数据做出明确断言时必须谨慎,但开展对照试验的局限性既不应排除使用设计良好的非随机对照试验的结果,更重要的是,也不应剥夺患者接受潜在有效治疗的机会。

相似文献

1
Evidence-based medicine works best when there is evidence: challenges in palliative medicine when randomized controlled trials are not possible.有证据时循证医学效果最佳:当无法进行随机对照试验时,姑息医学面临的挑战。
J Pain Palliat Care Pharmacother. 2009;23(1):48-50. doi: 10.1080/15360280902728237.
2
Prioritising drugs for single patient (n-of-1) trials in palliative care.在姑息治疗中对单患者(n-of-1)试验的药物进行优先排序。
Palliat Med. 2009 Oct;23(7):623-34. doi: 10.1177/0269216309106461. Epub 2009 Jul 15.
3
Can observational studies provide a realistic alternative to randomized controlled trials in palliative care?在姑息治疗中,观察性研究能否为随机对照试验提供切实可行的替代方案?
J Pain Palliat Care Pharmacother. 2009;23(2):106-13. doi: 10.1080/15360280902899921.
4
Qualitative research in evidence-based medicine: improving decision-making and participation in randomized controlled trials of cancer treatments.循证医学中的定性研究:提高癌症治疗随机对照试验的决策制定和参与度。
Palliat Med. 2011 Dec;25(8):758-65. doi: 10.1177/0269216311419548. Epub 2011 Aug 15.
5
Hierarchy of evidence: from case reports to randomized controlled trials.证据等级:从病例报告到随机对照试验。
Clin Orthop Relat Res. 2003 Aug(413):19-24. doi: 10.1097/01.blo.0000079323.41006.12.
6
Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials.提高姑息治疗干预措施的有效性:定性研究在增强随机对照试验证据方面的潜在作用。
Palliat Med. 2008 Mar;22(2):123-31. doi: 10.1177/0269216307087319.
7
Evidence-based pain management and palliative care in Issue One for 2006 of The Cochrane Library.《考科蓝图书馆》2006年第一期中基于证据的疼痛管理与姑息治疗。
J Pain Palliat Care Pharmacother. 2006;20(3):77-8.
8
Palliative care pharmacotherapy literature summaries and analyses.姑息治疗药物治疗文献综述与分析。
J Pain Palliat Care Pharmacother. 2009;23(2):174-81. doi: 10.1080/15360280902901404.
9
Palliative single-fraction radiation therapy: how much more evidence is needed?姑息性单次分割放射治疗:还需要多少证据?
J Natl Cancer Inst. 2005 Jun 1;97(11):786-8. doi: 10.1093/jnci/dji166.
10
Are opioids effective in the treatment of neuropathic pain?阿片类药物对神经性疼痛的治疗有效吗?
Am Fam Physician. 2007 Apr 1;75(7):999-1001.

引用本文的文献

1
Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.临终癌症患者症状控制的催眠疗法:一项系统评价
Int J Clin Exp Hypn. 2017 Jul-Sep;65(3):296-307. doi: 10.1080/00207144.2017.1314728.
2
Drug therapy optimization at the end of life.生命终末期的药物治疗优化。
Drugs Aging. 2012 Jun 1;29(6):511-21. doi: 10.2165/11631740-000000000-00000.